Galleri, The Blood Test That Can Detect Cancers, Is Up For FDA Approval Today

The FDA panel has endorsed the Galleri blood test, marking a significant milestone for the first-of-a-kind Multi-Cancer Early Detection (MCED) technology. This innovative testing field is experiencing rapid growth as the product seeks official FDA approval. The endorsement occurred at the FDA White Oak campus in Silver Spring, Maryland, on April 8, 2025. This development highlights the progress of MCED testing in identifying various cancers through a single blood sample for earlier medical intervention.